当前位置: X-MOL 学术J. Hypertens. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Utility of urinary albumin excretion as an index for stratifying the residual cardiovascular risk in patients undergoing antihypertensive agents treatment.
Journal of Hypertension ( IF 4.9 ) Pub Date : 2021-07-13 , DOI: 10.1097/hjh.0000000000002947
Yawara Kikuchi 1 , Fumitaka Tanaka 1 , Motoyuki Nakamura 1 , Kozo Tanno 2 , Toshiyuki Onoda 2 , Masaki Ohsawa 1 , Kiyomi Sakata 2 , Shinichi Omama 3 , Kuniaki Ogasawara 3 , Yuki Yonekura 4 , Kazuyoshi Itai 5 , Toru Kuribayashi 6 , Yasushi Ishigaki 1 , Akira Okayama 7 , Koichi Asahi 1 ,
Affiliation  

Patients treated with antihypertensive medication, even those with well controlled blood pressure (BP), are at higher risk for the development of atherosclerotic cardiovascular disease (ASCVD) in comparison to nonhypertensive individuals with optimal risk levels. We hypothesized that this residual risk could be stratified based on urinary albumin excretion (UAE).

中文翻译:

尿白蛋白排泄作为接受抗高血压药物治疗的患者残余心血管风险分层指标的效用。

与具有最佳风险水平的非高血压患者相比,接受抗高血压药物治疗的患者,即使是那些血压 (BP) 控制良好的患者,发生动脉粥样硬化性心血管疾病 (ASCVD) 的风险更高。我们假设可以根据尿白蛋白排泄 (UAE) 对这种残留风险进行分层。
更新日期:2021-07-17
down
wechat
bug